Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System.

Autor:	Gingold JA; Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York. Electronic address: jgingold@montefiore.org., Kucherov A; Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York; Illume Fertility, Norwalk, Connecticut., Wu H; Mailman School of Public Health, Columbia University, New York, New York., Fazzari M; Department of Epidemiology & Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York., Lieman H; Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York., Ball GD; Seattle Reproductive Medicine, Seattle, Washington; Reproductive Medicine and Infertility Associates, Woodbury, Minnestosa., Doody K; Center for Assisted Reproduction, CARE Fertility, Bedford, Texas., Jindal S; Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York.
Jazyk:	angličtina
Zdroj:	Fertility and sterility [Fertil Steril] 2024 Aug 10. Date of Electronic Publication: 2024 Aug 10.
DOI:	10.1016/j.fertnstert.2024.08.315
Abstrakt:	Objective: To evaluate the impact of preimplantation genetic testing for aneuploidy (PGT-A) on first transfer live birth rate (LBR) and cumulative LBR (CLBR) in donor oocyte in vitro fertilization (IVF) cycles. Design: Retrospective cohort study of the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database. Setting: Fertility centers reporting to Society for Assisted Reproductive Technology. Patient(s): A total of 11,348 fresh and 7,214 frozen-thawed donor oocyte IVF cycles were analyzed. Intervention(s): The first reported donor stimulation cycle per patient between January 1, 2014, and December 31, 2015, and all linked embryo transfer cycles between January 1, 2014, and December 31, 2016, were included in the study. Main Outcome Measure(s): Live birth rate was compared for patients using fresh and frozen-thawed donor oocytes, with or without PGT-A. Logistic regression models were adjusted for age, body mass index, gravidity, infertility etiology, and prior IVF cycles. Result(s): Among patients who had blastocysts available for transfer or PGT-A, the use of PGT-A was associated with a decreased first transfer LBR (46.9 vs. 53.2%) and CLBR (58.4 vs. 66.6%) in fresh oocyte donor cycles compared with no PGT-A. Live birth rate in frozen-thawed oocyte donor cycles with PGT-A were nominally higher than those without PGT-A (48.3% vs. 40.5%) but were not statistically significant in multivariable logistic regression models. Early pregnancy loss was not significantly different with and without PGT-A. Multiple gestation, preterm birth, and low birth weight infants were all reduced with the addition of PGT-A in fresh donor oocyte cycles, although these outcomes were not significantly different when comparing single embryo transfers in fresh oocyte cycles and also not significantly different among frozen-thawed donor oocyte cycles. Conclusion(s): Preimplantation genetic testing for aneuploidy in fresh oocyte donor cycles was associated with decreased LBR and CLBR, whereas effects on frozen-thawed oocyte donor cycles were clinically negligible. Obstetric benefits associated with PGT-A in fresh donor cycles appear linked to increased single embryo transfer. Competing Interests: Declaration of Interests J.A.G. has nothing to disclose. A.K. has nothing to disclose. H.W. has nothing to disclose. M.F. has nothing to disclose. H.L. has nothing to disclose. G.D.B. has nothing to disclose. K.D. has nothing to disclose. S.J. has nothing to disclose. (Copyright © 2024 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu